双能CT未见单钠尿酸盐结晶沉积的痛风患者是否更易治疗
在CRYSTALILLE队列中,211例未接受降尿酸治疗的痛风患者基线双能CT采用0.01 cm³与0.1 cm³两种阴性阈值,0.1 cm³阈值与临床表现及演变相关性更好;阴性患者病情较轻、共病负担较低,降尿酸达标率与阳性者无差异,但复发风险可能更低。
要点
- 0.1 cm³阈值较0.01 cm³阈值与痛风临床表现及演变的相关性更好。
- 双能CT阴性痛风患者病情较轻、共病负担较低,但降尿酸达标并不特别容易。
- 双能CT阴性患者复发风险可能更低,各时间点复发率差异未达统计学显著。
核心结论
- 0.1 cm³阈值较0.01 cm³阈值与痛风临床表现及演变的相关性更好。
- 双能CT阴性的痛风患者病情较轻、共病负担较低。
- 双能CT阴性患者的高尿酸血症并不特别容易治疗,但复发风险可能更低。
研究设计与样本
- 研究纳入CRYSTALILLE队列中确诊痛风、未接受降尿酸治疗且具有基線膝关节和足部双能CT扫描的患者。
- 采用0.01 cm³和0.1 cm³两种阳性阈值判定双能CT单钠尿酸盐结晶沉积,并与阳性患者比较基線特征及降尿酸治疗后的关键结局。
主要发现
- 共纳入211例患者,中位年龄66.2岁(四分位距57-75.8),中位症状持续时间3年(四分位距0-7.8)。
- 38/211(18%)和90/211(43%)的患者分别在0.01 cm³和0.1 cm³阈值下双能CT阴性。
- 两个体积阈值下,双能CT阴性与较年轻、症状持续时间较短及无心血管疾病相关。
- 双能CT<0.1 cm³组在6、12、24个月复发分别为9/39(23.1%)、3/26(11.5%)、1/18(5.6%),≥0.1 cm³组分别为18/45(40.0%)、9/36(25.0%)、2/18(11.1%),P>0.05。
- 95例(68.3%)达到血清尿酸<6.0 mg/dl,68例(48.9%)达到<5.0 mg/dl,双能CT阳性与阴性组间无差异,阴性组降尿酸治疗剂量倾向于更低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the clinical associations and predictive value of two thresholds of negative dual-energy CT (DECT) for MSU crystal deposition in gout patients initiating urate-lowering therapy (ULT) and identify which threshold is more clinically relevant. METHODS: Patients from the CRYSTALILLE cohort with a diagnosis of gout naïve to ULT with baseline DECT scans of the knees and feet were selected. Two thresholds of positivity for DECT detection of MSU crystal deposition were considered (<0.01 cm3 and <0.1 cm3). Baseline characteristics and the prediction of key outcomes after ULT initiation, including reaching serum urate (SU) levels <6.0 and 5.0 mg/dl and occurrence of flares at 6, 12 and 24 months, associated with both thresholds of negative DECTs were compared with those of patients having positive DECT scans. RESULTS: A total of 211 patients, median age 66.2 years [interquartile range (IQR) 57-75.8], with a median symptom duration of 3 years (IQR 0-7.8) were included. A total of 38/211 (18%) and 90/211 (43%) had negative DECT scans for the 0.01 and 0.1 cm3 thresholds, respectively. Factors associated with negative DECT scans were younger age, shorter symptom duration and an absence of cardiovascular disease for both volume thresholds. A total of 9/39 (23.1%), 3/26 (11.5%) and 1/18 (5.6%) patients with <0.1 cm3 MSU crystals had flares at 6, 12 and 24 months, respectively, compared with 18/45 (40.0%), 9/36 (25.0%) and 2/18 (11.1%) patients with ≥0.1 cm3 (P > 0.05). Overall, 95 patients (68.3%) reached SU levels <6.0 mg/dl and 68 (48.9%) reached levels <5.0 mg/dl, without any difference between positive and negative DECTs, with ULT dosages that tended to be lower in patients with negative DECTs. CONCLUSION: The 0.1 cm3 threshold was better correlated with clinical presentation and evolution than the 0.01 cm3 threshold. Gout patients with negative DECTs exhibit milder disease and a lower comorbidity burden. They do not exhibit particularly easy-to-treat hyperuricaemia but they may have a lower risk of flares.
引用
- Laurent V, Jauffret C, Ducoulombier V, et al. Are gout patients with negative dual-energy computed tomography for monosodium urate crystal deposition easy to treat? Rheumatology (Oxford). 2025. PMID: 38336883. doi:10.1093/rheumatology/keae061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。